1. Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide
   María Belén Novoa Díaz et al, 2022, World Journal of Gastroenterology CrossRef
2. Modified chitosan nanogel-polymersomes for oral co-delivery of oxaliplatin and rapamycin for synergistic chemotherapy
   Dickson Pius Wande et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
3. Solanum torvum induces ferroptosis to suppress hepatocellular carcinoma
   Hsiang-Chun Lai et al, 2024, Journal of Ethnopharmacology CrossRef
4. Rapamycin enhanced the antitumor efficacy of oxaliplatin in cisplatin-resistant ovarian cancer cells A2780cis bothin vitroandin vivo
   Jin Liu et al, 2015, Journal of Chemotherapy CrossRef
5. A phase 1b study of OXIRI in pancreatic adenocarcinoma patients and its immunomodulatory effects
   Matthew Ng et al, 2022, International Journal of Cancer CrossRef
6. Antitumor Activity of Ruthenium(II) Terpyridine Complexes towards Colon Cancer Cells In Vitro and In Vivo
   Maja Savic et al, 2020, Molecules CrossRef
7. Phosphorylated mTOR expression as a predictor of survival after liver resection for colorectal liver metastases
   Takanori Konishi et al, 2021, Journal of Surgical Oncology CrossRef
8. Combination of temsirolimus and adriamycin exhibits an enhanced antitumor effect in hepatocellular carcinoma
   Hong-Gang Kang et al, 2017, Clinics and Research in Hepatology and Gastroenterology CrossRef